arrow
G

Georg Ebersbach

movement disorders hospital beelitz
H指数:43
被引数:6,711

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Early start of opicapone in Parkinson’s disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of motor fluctuations

帕金森病中奥匹卡朋的早期开始:来自一项合并分析的证据,该分析基于3期试验,表明对于近期出现运动波动的患者具有持续获益。

2025-12-150
OAAI
Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson Disease
2023-11-214
PRE
Safety and efficacy of anti-tau monoclonal antibody gosuranemab in progressive supranuclear palsy: a phase 2, randomized, placebo-controlled trial (August, 10.1038/s41591-021-01455-x, 2021)

抗tau单克隆抗体gosuranemab治疗进行性核上性麻痹的安全性和有效性: 一项2期,随机,安慰剂对照试验 (8月,10.1038/s41591-021-01455-x,2021)

2022-10-171
OA